GSBR-1290 — clinical trials using this drug

Public-registry trials using GSBR-1290 that Eichor's radar has found — 1 trial. All data below is from public sources; Eichor is not affiliated with any sponsor.

Trial	Sponsor	Condition	Phase	Sites
Phase 1b/2a Study of GSBR-1290 in Adult Overweight or Obese Healthy Subjects and Subjects With Type 2 Diabetes Mellitus	Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics	Overweight or Obesity	PHASE1 / PHASE2	4

Registry history

First registered study	March 2023 — NCT05762471 (Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics)
Registered studies matching this name	8 all-time · 0 currently recruiting

Source: ClinicalTrials.gov, the public trial registry.

Free site-risk snapshot for any of these trials

Eichor generates a preliminary site-risk snapshot — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →

Related drugs & trials

Trialed alongside

Placebo

Other Overweight or Obesity drugs

← Eichor home · All tracked trials · Overweight or Obesity studies · Weekly briefs

Planning or rescuing a trial? Eichor generates evidence-linked site-risk reports from public data in minutes. Get a free preliminary snapshot →